BioNTech SE
BNTX
$89.93
-$0.95-1.05%
Weiss Ratings | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | C | |||
Rating Factors | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Good | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.79 | |||
Price History | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 5.42% | |||
30-Day Total Return | 1.11% | |||
60-Day Total Return | -1.21% | |||
90-Day Total Return | -12.30% | |||
Year to Date Total Return | -17.47% | |||
1-Year Total Return | -14.19% | |||
2-Year Total Return | -34.25% | |||
3-Year Total Return | -54.70% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -27.78% | |||
52-Week Low % Change | 6.65% | |||
Price | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $125.83 | |||
52-Week Low Price | $85.21 | |||
52-Week Low Price (Date) | Mar 20, 2024 | |||
52-Week High Price (Date) | Aug 31, 2023 | |||
Valuation | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 22.34B | |||
Enterprise Value | 4.29B | |||
Price/Earnings (TTM) | 22.56 | |||
Earnings Per Share (TTM) | 4.11 | |||
Earnings Per Share Growth | -89.56% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 5.43 | |||
Price/Book (Q) | 0.98 | |||
Enterprise Value/Revenue (TTM) | 3.03 | |||
Price | $92.72 | |||
Enterprise Value/EBITDA (TTM) | 10.52 | |||
Enterprise Value/EBIT | 12.04 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 241.00M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | $1.55 | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $1.55 | |||
Company Info | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 49 6131 9084 0 | |||
Address | -- | |||
Website | www.biontech.de | |||
Country | Germany | |||
Year Founded | 2008 | |||
Profitability | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 25.15% | |||
Profit Margin | 24.25% | |||
Management Effectiveness | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 2.57% | |||
Return on Equity | 4.56% | |||
Income Statement | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 4.12B | |||
Total Revenue (TTM) | 4.12B | |||
Revenue Per Share | $17.09 | |||
Gross Profit (TTM) | 3.47B | |||
EBITDA (TTM) | 1.19B | |||
EBIT (TTM) | 1.04B | |||
Net Income (TTM) | 999.08M | |||
Net Income Avl. to Common (TTM) | 999.08M | |||
Total Revenue Growth (Q YOY) | -63.58% | |||
Earnings Growth (Q YOY) | -78.83% | |||
EPS Diluted (TTM) | 4.11 | |||
EPS Diluted Growth (Q YOY) | -78.42% | |||
Balance Sheet | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 18.29B | |||
Cash Per Share (Q) | $75.90 | |||
Total Current Assets (Q) | 21.58B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 22.38B | |||
Current Ratio (Q) | 9.431 | |||
Book Value Per Share (Q) | $94.14 | |||
Total Assets (Q) | 25.43B | |||
Total Current Liabilities (Q) | 2.29B | |||
Total Debt (Q) | 242.18M | |||
Total Liabilities (Q) | 3.05B | |||
Total Common Equity (Q) | 22.38B | |||
Cash Flow | BNTX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -7.53B | |||
Cash from Financing (TTM) | -842.64M | |||
Net Change in Cash (TTM) | -2.36B | |||
Levered Free Cash Flow (TTM) | 4.51B | |||
Cash from Operations (TTM) | 5.85B | |||